The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 984.00
Bid: 982.00
Ask: 986.00
Change: 6.00 (0.61%)
Spread: 4.00 (0.407%)
Open: 997.00
High: 1,004.00
Low: 977.00
Prev. Close: 978.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options under CVS Group plc

24 Nov 2023 15:56

RNS Number : 6472U
CVS Group plc
24 November 2023
 

 

 

24 November 2023

CVS Group plc

("CVS" or the "Company")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2023/2024 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors and the person closely associated (PCA) named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman 550 SAYE scheme options

Robin Alfonso 550 SAYE scheme options

Ben Jacklin 517 SAYE scheme options

Katherine Jacklin (PCA to Ben Jacklin) 550 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,146 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2023, being the invitation date.

 

In response to accepted invitations, a total of 558,994 SAYE Scheme options over Ordinary Shares were granted on 24 November 2023, equating to 0.79% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2027.

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison Group Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p

550

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p

550

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Deputy CEO

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p

 

517

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Katherine Jacklin

2

Reason for the notification

a)

Position/status

PCA to Deputy CEO Ben Jacklin

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p

 

550

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBIBATMTATBTJ
Date   Source Headline
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.